Answers are grounded in this paper and cite their sources.
Summary: Given the malleable nature of cancer cells, we should expect, and do see, the development of resistance to any new chemotherapeutic agent. Models that help us understand how this happens are a first step to better and more effective chemotherapeutics. Cancer Discov; 3(1); 20–3.
No takes yet. Share an insight, caveat, or question.
Fojo et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: